新闻

CDW: Subsidiary ABio & Neoregen Sign Joint R&D Agreement For Next-Generation Lipid Nanoparticle Technology.

20 Jan 2025 14:06

Joint R&D agreement enables Neoregen and ABio to deepen research into LNP technology and mRNA vaccines...

Attachments:

• CDW_MR_-_ABio_Update_Final.pdf

Source: ShareInvestor Express